Article
Influenza vaccination: What’s new this season
One IIV trivalent product can now be given with a needle-free jet injector. A recombinant vaccine formulation is available for those who have egg...
Article
Breast cancer screening: The latest from the USPSTF
Mammography for women ages <50 years remains controversial except for selected individuals. Data are insufficient to recommend for or against...
Article
Catching up on the latest USPSTF recommendations
Screening is now encouraged for hepatitis B in those at high risk and for gestational diabetes at 24 weeks gestation. Low-dose aspirin is also...
Article
Immunization update: What’s changed, what’s on the way
A 9-valent HPV vaccine may soon be marketed and 2-dose schedules could be on the horizon. Two new meningococcal B vaccines will also be available...
Article
Pneumococcal vaccines for older adults: Getting the timing right
ACIP now advises that older adults receive both PCV13 and PPSV23, but not at the same time. The interval between the 2 depends on which is...
Audio
Ebola: The facts FPs need to know
Doug Campos-Outcalt, MD, MPA, discusses what you need to know about Ebola and the 3 steps you'll need to take if you suspect your patient may have...
Article
The 2014-2015 influenza season: What you need to know
A nasal spray vaccine is now preferred for children ages 2 through 8 years.
Article
Diet, exercise, and CVD: When counseling makes the most sense
The USPSTF advises high-intensity counseling for those who are overweight or obese and have hypertension, hyperlipidemia, or other CVD risk...
Article
USPSTF: What’s recommended, what’s not
Twenty-six recommendations were issued last year. Two screening procedures previously unsupported by good evidence are now firmly advocated; 4...
Article
Immunization update: The latest ACIP recommendations
A third meningococcal vaccine broadens coverage for children at high risk of infection. The 13-valent pneumococcal vaccine is now available for...
Article
The new cardiovascular disease prevention guidelines: What you need to know
A new, partially tested CVD risk-assessment tool significantly increases the number of individuals who would qualify for statin therapy. Treating...
